Novartis, AstraZeneca Cede Seed Business: Two Pharma Pure Plays Created

The Novartis/AstraZeneca agribusiness spin-off reflects the "limited" synergies between the agricultural and pharmaceutical businesses, the two companies maintained.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet